メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
藤田医科大学 ホーム
English
日本語
ホーム
プロファイル
研究部門
研究成果
専門知識、名前、または所属機関で検索
医学部・腎臓内科学
藤田医科大学
医学部
概要
フィンガープリント
ネットワーク
プロファイル
(4)
研究成果
(56)
フィンガープリント
医学部・腎臓内科学が活動している研究トピックを掘り下げます。これらのトピックラベルは、この組織のメンバーの研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Medicine and Dentistry
Prospective Cohort Study
100%
Vasculitis
70%
Proteinuria
64%
Cohort Analysis
63%
Rapidly Progressive Glomerulonephritis
45%
Acute Kidney Injury
42%
Minimal Change Disease
42%
Nephrosclerosis
42%
Kidney Function
40%
Nephrotic Syndrome
38%
Neutrophil Cytoplasmic Antibody
36%
Nephropathy
32%
ANCA Associated Vasculitis
32%
Pediatrics
28%
Glomerular Filtration Rate
28%
Renal Biopsy
26%
Microscopic Polyangiitis
26%
All Cause Mortality
26%
Spontaneous Remission
26%
Glomerulonephritis
25%
Hazard Ratio
24%
Serum Albumin
23%
Prospective Study
22%
Glucocorticoid
22%
Chronic Kidney Disease
21%
Retrospective Cohort Study
21%
Polycystic Kidney Disease
21%
Lipoprotein Apheresis
21%
Low-Density Lipoprotein
21%
Patient with Diabetes
21%
Peritoneal Dialysis
21%
Focal Segmental Glomerulosclerosis
21%
Diabetes Mellitus
21%
Cross Sectional Study
21%
Vasculotropin
21%
Dyslipidemia
21%
Macroalbuminuria
21%
Ferrous Sulfate
21%
Granulomatosis with Polyangiitis
21%
Vasculotropin A
21%
Resting Heart Rate
21%
Peritonitis
21%
Gene Expression Profiling
21%
Heart Muscle Ischemia
21%
Prednisolone
20%
Diabetic Nephropathy
18%
Survival Rate
18%
Low Drug Dose
17%
Cumulative Incidence
16%
Infection
15%
Mortality Rate
15%
Rituximab
14%
Roluperidone
14%
Proportional Hazards Model
13%
End Stage Renal Disease
13%
Cyclophosphamide
12%
Diabetes
12%
Heat Map
12%
Drug Megadose
12%
Creatinine
11%
Myeloperoxidase
11%
Immunosuppressive Treatment
10%
Cardiovascular System
8%
Glomerulosclerosis
8%
Onset Age
8%
Propensity Score Matching
7%
Myeloblastin
7%
Nephrology
7%
Blood Purification
7%
Etiology
7%
Intensive Care Medicine
7%
Clinical Guideline
7%
Divalent
7%
Autosomal Recessive Inheritance
6%
Anti-Glomerular Basement Membrane Antibody
6%
Immunoglobulin A Nephropathy
6%
Log Rank Test
6%
Urinary System
5%
Biopsy
5%
Elderly Patient
5%
Odds Ratio
5%
Logistic Regression Analysis
5%
Biopsy Sample
5%
Hand-Schüller-Christian Disease
5%
Patient Characteristics
5%
Osteoporosis
5%
Weakness
5%
Immunosuppressive Drug
5%
Cataract
5%
Pitavastatin
5%
Cardiovascular Disease
5%
Keyphrases
Prospective Cohort Study
48%
Remission of Proteinuria
42%
Minimal Change Disease
42%
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
42%
Acute Kidney Injury
42%
Clinical Practice Guidelines
42%
Time to Remission
42%
Remission
39%
Japan
39%
Nephrotic Syndrome
32%
MPO-ANCA
28%
Multicenter Cohort Study
27%
Adult Patients
24%
Vasculitis Damage Index
23%
Steroid-sensitive
21%
Early Remission
21%
Lipoprotein Apheresis
21%
Proteinuria
21%
Darbepoetin Alfa
21%
Dyslipidemia
21%
Hemoglobin Level
21%
Outcome Analysis
21%
Ferrous Sulfate
21%
Ferric Citrate
21%
Patients with Diabetes Mellitus
21%
N-glycosylation
21%
FcRI
21%
IgA1
21%
Safety Outcomes
21%
Treatment-related
21%
Damage Accrual
21%
Peritoneal Dialysis Outcome
21%
Elderly Onset
21%
Therapeutic Apheresis
21%
Cytoplasmic Antibodies
21%
Hypertensive Nephrosclerosis
21%
Kidney Biopsy
21%
Focal Segmental Glomerulosclerosis
21%
Activity Participation
21%
Targeted Proteomics
21%
Subgroup Analysis
21%
Serum Albumin Concentration
21%
Resting Heart Rate
21%
Heart Rate
21%
Dialysis Efficiency
21%
Retrospective Cohort Study
21%
Prednisolone
21%
Chronic Kidney Disease
21%
Clinical Outcomes
21%
Renal Function Improvement
21%
Chronic Coronary Syndrome
21%
Kidney End Point
16%
Heat Map
16%
Cumulative Incidence
16%
High Dose
16%
Transketolase
15%
CD93
15%
Diabetes
14%
Properdin
14%
Index Score
14%
Serious Infection
14%
Adverse Cardiac Events
14%
Renal Function
14%
Cerebral Events
14%
Clinical Setting
14%
Confidence Interval
13%
Multivariable
11%
Kidney Events
10%
Antineutrophil Cytoplasmic Antibody
10%
Odds Ratio
10%
ANCA-associated Vasculitis
10%
Serum Creatinine Level
9%
Tenascin-C
9%
Cox Proportional Hazards Model
8%
Immunosuppressive Therapy
8%
Conflicting Results
8%
Estimated Glomerular Filtration Rate
8%
Patients with Diabetes
8%
Certified Reference Material
8%
Pediatric
7%
Blood Purification
7%
Nephrology
7%
Intensive Care Medicine
7%
Injury Management
7%
Early Intervention
7%
Etiological Factors
7%
Early Detection
7%
Clinical Practice
7%
Multidisciplinary Approach
7%
Literature Search
7%
Significant Predictors
7%
Dialysis Initiation
7%
Rapid Reduction
7%
Complement Components
7%
Hypertension
7%
Patient Outcomes
7%
Patient Characteristics
7%
Osteoporosis
7%
Primary Kidney Disease
7%
EUVAS
7%
Pharmacology, Toxicology and Pharmaceutical Science
Remission
84%
Prospective Cohort Study
72%
Cohort Study
71%
Vasculitis
47%
ANCA Associated Vasculitis
47%
Proteinuria
42%
Acute Kidney Failure
42%
Disease
42%
Neutrophil Cytoplasmic Antibody
32%
Nephrotic Syndrome
27%
Glomerulonephritis
25%
Diseases
25%
Biological Marker
25%
Rapidly Progressive Glomerulonephritis
23%
Disease Activity
23%
Chronic Kidney Failure
21%
Focal Glomerulosclerosis
21%
Prospective Study
21%
Nephrosclerosis
21%
Ferrous Sulfate
21%
Rheumatoid Arthritis
21%
Macroalbuminuria
21%
Stromelysin
21%
Tissue Inhibitor of Metalloproteinase 1
21%
Heart Muscle Ischemia
21%
Prednisolone
20%
Glucocorticoid
17%
Infection
15%
Diabetic Nephropathy
14%
Adsorption
14%
Roluperidone
14%
Survival Rate
13%
Rituximab
12%
Serum Albumin
12%
Immunoglobulin A
10%
Creatinine
9%
Cyclophosphamide
8%
Onset Age
8%
Immunosuppressive Agent
8%
Etiology
7%
Syndrome
7%
End Stage Renal Disease
7%
Kidney Disease
7%
Randomized Controlled Trial
7%
Endotoxin
7%
Collagen Disease
7%
Gastroenterology
7%
Methotrexate
7%
Infliximab
7%
Polymyxin B
7%
Heart Failure
7%
Microscopic Polyangiitis
6%
Wegener Granulomatosis
6%
Immunoglobulin A Nephropathy
5%
Myeloperoxidase
5%
Ion Cyclotron Resonance
5%
Surface Plasmon Resonance
5%
Weakness
5%
Cataract
5%
Myeloblastin
5%
Pitavastatin
5%